These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2598021)

  • 1. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH; Leung LW; Baker GB; Stewart DJ
    Brain Res; 1989 Dec; 504(2):181-91. PubMed ID: 2598021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH
    Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of serotonin-dependent cerebral activation: a possible mechanism of action of some psychotomimetic drugs.
    Vanderwolf CH
    Brain Res; 1987 Jun; 414(1):109-18. PubMed ID: 3620913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentation of the hippocampus.
    Altman HJ; Normile HJ; Galloway MP; Ramirez A; Azmitia EC
    Brain Res; 1990 Jun; 518(1-2):61-6. PubMed ID: 1697213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior.
    Vanderwolf CH; Baker GB
    Brain Res; 1986 May; 374(2):342-56. PubMed ID: 2941111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
    Robertson B; Baker GB; Vanderwolf CH
    Brain Res; 1991 Aug; 555(2):265-75. PubMed ID: 1933339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

  • 8. Joint cholinergic-serotonergic control of neocortical and hippocampal electrical activity in relation to behavior: effects of scopolamine, ditran, trifluoperazine and amphetamine.
    Vanderwolf CH; Stewart DJ
    Physiol Behav; 1986; 38(1):57-65. PubMed ID: 3786502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
    Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
    Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
    [No Abstract]   [Full Text] [Related]  

  • 11. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine.
    Larsson K; Fuxe K; Everitt BJ; Holmgren M; Södersten P
    Brain Res; 1978 Feb; 141(2):293-303. PubMed ID: 626904
    [No Abstract]   [Full Text] [Related]  

  • 12. 5,7-Dihydroxytryptamine lesions of the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat.
    Carter CJ; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):235-8. PubMed ID: 7190651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists.
    Watson NV; Hargreaves EL; Penava D; Eckel LA; Vanderwolf CH
    Brain Res; 1992 Nov; 597(1):16-23. PubMed ID: 1477730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic denervation partially protects rat striatum from kainic acid toxicity.
    Berger M; Sperk G; Hornykiewicz O
    Nature; 1982 Sep; 299(5880):254-6. PubMed ID: 6213866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
    Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental alterations in 5-hydroxytryptamine concentration and turnover after treatment of neonatal rats with 5,7-dihydroxytryptamine.
    Mercugliano M; Nguyen H; Djali S; Lucki I
    Neurobiol Learn Mem; 1996 Mar; 65(2):163-76. PubMed ID: 8833105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
    Pranzatelli MR; Eng B
    Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocortical activation: modulation by multiple pathways acting on central cholinergic and serotonergic systems.
    Dringenberg HC; Vanderwolf CH
    Exp Brain Res; 1997 Aug; 116(1):160-74. PubMed ID: 9305825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
    Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
    Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.